Literature DB >> 7926459

Decreased bilirubin transport in the perfused liver of endotoxemic rats.

H Roelofsen1, C N van der Veere, R Ottenhoff, B Schoemaker, P L Jansen, R P Oude Elferink.   

Abstract

BACKGROUND/AIMS: Hyperbilirubinemia associated with sepsis is frequently observed in humans. In this study, an experimental rat model was developed to study bilirubin metabolism and transport during endotoxemia.
METHODS: Rats were injected intravenously with a single bolus of lipopolysaccharide (1 mg/kg); after 18 hours, the liver was removed for single-pass perfusion. Unconjugated bilirubin, bilirubin ditaurate (125 nmol/min), and/or taurocholate (1.5 mumol/min) were infused. Rate constants for uptake were determined from the disappearance of a bolus of bilirubin ditaurate in a recirculating perfusion.
RESULTS: In endotoxemic livers, biliary excretion of bilirubin-glucuronides was reduced by 49% (2.04 +/- 0.2 and 3.99 +/- 0.24 nmol.min-1.g liver-1). Similar results were obtained with bilirubin ditaurate, indicating that the reduced transport is not caused by a reduced conjugation capacity. The rate constant of sinusoidal uptake was significantly reduced during endotoxemia (0.191 +/- 0.034 vs. 0.090 +/- 0.035, respectively). Secretion of taurocholate into bile was also reduced (92 +/- 22 vs. 127 +/- 10 nmol.min-1.g liver-1).
CONCLUSIONS: In endotoxemic rats, biliary clearance of bilirubin and taurocholate is substantially decreased, suggesting that decreased output of bilirubin-glucuronides is not caused by impaired conjugation but by a reduction in transport.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926459     DOI: 10.1016/0016-5085(94)90232-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

Review 1.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

2.  Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography.

Authors:  H R Rosen; P J Winkle; B J Kendall; D L Diehl
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

3.  Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors.

Authors:  M Trauner; M Arrese; H Lee; J L Boyer; S J Karpen
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Effect of endotoxin on opossum gallbladder motility: a model of acalculous cholecystitis.

Authors:  J J Cullen; E B Maes; S Aggrawal; J L Conklin; K S Ephgrave; F A Mitros
Journal:  Ann Surg       Date:  2000-08       Impact factor: 12.969

Review 5.  Liver involvement in systemic infection.

Authors:  Masami Minemura; Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2014-09-27

6.  Distribution of heme oxygenase isoforms in rat liver. Topographic basis for carbon monoxide-mediated microvascular relaxation.

Authors:  N Goda; K Suzuki; M Naito; S Takeoka; E Tsuchida; Y Ishimura; T Tamatani; M Suematsu
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

7.  Hyperbilirubinemia as a predictive factor in acute appendicitis.

Authors:  T Eren; E Tombalak; I A Ozemir; M Leblebici; S Ziyade; O Ekinci; O Alimoglu
Journal:  Eur J Trauma Emerg Surg       Date:  2015-08-08       Impact factor: 3.693

8.  IL-6 modulates sepsis-induced decreases in transcription of hepatic organic anion and bile acid transporters.

Authors:  Kenneth M Andrejko; Nichelle R Raj; Patrick K Kim; Maurizio Cereda; Clifford S Deutschman
Journal:  Shock       Date:  2008-04       Impact factor: 3.454

9.  Liver failure following partial hepatectomy.

Authors:  Thomas S Helling
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 10.  Cholestasis.

Authors:  R Oude Elferink
Journal:  Gut       Date:  2003-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.